Am I a patient at risk?
I had breast cancer – but I feel healthy now and my follow-up care has been unremarkable recently – am I in the risk group?
The answer is no. Women after breast cancer are not more likely to get infectious diseases. They are now just as healthy as their neighbor and should feel that way.
This is also true for women who have had chemotherapy in the past. Your immune system has been impaired by chemotherapy only for a short period of time – usually you can assume that with the recovery of the white blood cells (leukocytes) a proper immune defense is in place.
I am taking anti-hormonal therapy – am I at risk?
No – women on or following anti-hormonal therapy (e.g. Tamoxifen/Nolvadex, Anastrozole/Arimidex, Letrozole/Femara, Exemestane/Aromasin, Faslodex/Fulvestrant) are no longer at risk.
I have finished my chemotherapy and am receiving infusions with antibodies (e.g. Trastuzumab/Herceptin or Pertuzumab/Perjeta) – am I at risk?
No – as long as your blood count has recovered from chemotherapy, you are not at increased risk.
Who are those women we need to classify as at risk?
a) Patients who are currently receiving chemotherapy.
b) Patients taking so-called CDK4/6 inhibitors (Palbociclib/Ibrance, Ribociclib/ Kisqali, Abemaciclib/Vercenios).
c) Patients with advanced disease who require long-term therapies – e.g. everolimus/finitor, alpelisib/picray, cortisone preparations.
Patients who fall under category 4: please contact your treating oncologist.
Further information can be found under Krebsliga.